Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
about
SNAP-23 and VAMP-3 contribute to the release of IL-6 and TNFα from a human synovial sarcoma cell lineEmerging opportunities for serotypes of botulinum neurotoxinsTNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion.Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into NeuronsStructural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/DStructure of dual receptor binding to botulinum neurotoxin BCrystal Structures of Botulinum Neurotoxin DC in Complex with Its Protein Receptors Synaptotagmin I and IIIdentification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin APuzzling Out Synaptic Vesicle 2 Family Members Functions.Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins.Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestineCytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival.Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus.Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress.Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neuronsActivity of botulinum neurotoxin type D (strain 1873) in human neurons.Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle RecyclingThe receptor binding domain of botulinum neurotoxin serotype C binds phosphoinositides.Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pHUnique biological activity of botulinum D/C mosaic neurotoxin in murine species.A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.Clinical uses of botulinum neurotoxins: current indications, limitations and future developmentsProgress in cell based assays for botulinum neurotoxin detectionBotulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.Current strategies for designing antidotes against botulinum neurotoxins.Infection, Pain, and Itch.Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry.Bacterial Signaling to the Nervous System through Toxins and Metabolites.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons.A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.Engineered botulinum neurotoxin B with improved efficacy for targeting human receptorsIntegration of Synaptic Vesicle Cargo Retrieval with Endocytosis at Central Nerve Terminals.Identification and characterization of a novel botulinum neurotoxin.
P2860
Q24316444-8B410FF4-8E4B-498C-821C-F6CF424CC457Q26859917-D481395B-5A3B-473E-A7B2-9B4F82436914Q27348801-AFE4B81D-DF1F-4277-9B84-587DF8B3BD79Q27668123-9F61FCFA-51A4-434B-9AB5-AC995AEAB395Q27677003-AFE875FF-98EF-4B10-9B05-804333E4F2FEQ27678834-824C2A92-4972-43BB-A624-36ACB0A95AABQ27679493-B287ED36-2141-45A5-9F3B-F9868F89EDE7Q28581589-A3B503AA-ED80-404B-AD97-9495F4077F48Q33710870-0CA8D1D3-8C4B-4743-A104-9E5D5D5ECE13Q33793263-FF693562-58EB-451E-98A9-DFBF03E36BC1Q33882815-DE33BA18-4319-4CF7-A1FE-32A84F2B5E58Q34205889-41D8C5AD-8F75-48DD-AA14-91B4C2D26B00Q34327453-5CE9DB31-2593-4019-AD07-40D92DCC62E2Q34449930-44AD9D0C-FCAD-4E6B-A4D0-4CFCC089BD6BQ34733600-3C2C0D45-381B-4CA5-B695-AE94E0FEE78BQ34797732-1CF3D24C-FF64-42A1-9640-147956652640Q35563112-EF19B885-9E32-47AC-BC9A-0E865989B568Q35684016-C8DBF1F1-D9DF-427E-924F-FDD6D88C63BFQ35690475-FC69FADC-521E-4730-920B-0F349ACA80D5Q35710270-8734A637-AB12-4E9A-91D3-98133C4D9DD1Q35751422-D9C14EED-BA22-4BBE-857A-ED4B078422C6Q36099792-59BE1809-F993-49A3-8986-9E80EC9E78E3Q36211139-0131AEAF-4E12-47A6-86DB-3AAAE5F9FD17Q36376074-A3C15696-83A8-471F-9FA7-716F890174ADQ36395728-D746BD0C-D77F-4F40-B849-0C0BE6369C84Q36818335-AEDE0A82-14C7-46F6-803B-75FCDFD47D11Q36946982-14A49500-D35D-4AA2-9220-EE603730A96FQ37276819-00F8FBF1-17CC-4A1F-8397-4FC87772DA69Q37641175-5AF3288C-DDF4-44C4-B19A-4639E37B1F63Q38080382-8950D5BA-558F-41A3-9A16-E230BFDE2B3FQ38187441-FE93619A-F112-4B8A-9514-761E40E38961Q38763491-310774E6-20C3-485E-A55F-6648692EDE75Q38847565-138DEC85-CE68-4C8F-B965-77980D768906Q39075039-BAC28AD0-051A-4DFB-A52C-C65C56C21484Q39207459-B51B1F87-9928-4001-8F16-0AC315141FC3Q39500669-68A6182B-D9AD-42E3-932F-E8D3F641A36AQ40102969-BA791753-A0D2-4EF7-B0CE-AF8FFC0818BCQ40971832-90BF7B9D-BC91-446C-8ECA-46D241494ABCQ41222236-10013AEA-3BF3-4740-86F9-5CD8055EEAEFQ41245604-8D7C6648-2A6F-4886-83CE-0EF2C887A0AF
P2860
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@ast
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@en
type
label
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@ast
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@en
prefLabel
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@ast
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@en
P2093
P2860
P1433
P1476
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
@en
P2093
Eric A Johnson
Lisheng Peng
William H Tepp
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002008
P577
2011-03-31T00:00:00Z